Paul Conlin, MD

Adjunct Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Conlin is Chief, Medical Service at VA Boston Healthcare System, Professor of Medicine at Harvard Medical School and Maurice Strauss Chair at Chobanian and Avedisian School of Medicine. He is also Director of the Clinical and Translational Research Academy in Harvard Catalyst - The Harvard Clinical and Translational Science Center. Dr. Conlin has been a practicing endocrinologist at VA Boston since 1989 and is Chair, VA Diabetes-Endocrinology Field Advisory Committee. His research focuses on improving patient-centered care for individuals with diabetes mellitus using information technology and health services approaches.

He has conducted clinical trials on the effects of dietary patterns and blood pressure regulation and studied patients with poorly controlled diabetes using e-health platforms and care management. He was a key architect of the VA’s national teleretinal imaging program to screen for diabetic retinopathy. His current research uses health services approaches to study clinical outcomes in patients with diabetes, focusing on hemoglobin A1c variability and medication cost-effectiveness.

Publications

  • Published 9/1/2026

    Reaven PD, Macwan SA, McConeghy K, Norman GJ, Conlin PR, Miller DR, Zhou JJ. Continuous Glucose Monitoring Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration. Diabetes Care. 2026 Sep 01; 49(9):1589-1598. PMID: 42319755.

    Read at: PubMed

  • Published 7/10/2026

    Hussain T, Juraschek SP, Miller ER, Sacks FM, Conlin PR, Svetkey L, Moore T, Appel LJ. The Effects of Sodium Reduction and the DASH Diet on Ambulatory Blood Pressure: Overall and Race-Stratified Results from the DASH-Sodium Trial. Am J Hypertens. 2026 Jul 10. PMID: 42429484.

    Read at: PubMed

  • Published 5/1/2026

    Conlin PR, Prentice JC, Mohr DC, Zhang L, Li D, Pleasants E, Nelson RE, Vupputuri S, Nichols GA. Haemoglobin A1c Time-In-Range and Mortality in Adults With Diabetes. Endocrinol Diabetes Metab. 2026 May; 9(3):e70197. PMID: 41904972.

    Read at: PubMed

  • Published 11/4/2025

    Conlin PR, Prentice JC, Mohr DC, Zhang L, Li D, Pleasants E, Nelson RE, Vupputuri S, Nichols GA. Hemoglobin A1c time-in-range, mortality, and diabetes complications in older adults with diabetes. BMJ Open Diabetes Res Care. 2025 Nov 04; 13(6). PMID: 41192934.

    Read at: PubMed

  • Published 3/8/2025

    Vimalananda VG, Kragen B, Leibowitz AJ, Qian S, Wormwood J, Linsky AM, Underwood P, Conlin PR, Kim B. Determinants of implementation of continuous glucose monitoring for patients with Insulin-Treated type 2 diabetes: a national survey of primary care providers. BMC Prim Care. 2025 Mar 08; 26(1):68. PMID: 40057678.

    Read at: PubMed

View All 131 Publications:   View Full Profile in BUMC

Websites

Education

  • University of Massachusetts Medical School, MD
  • Boston College, BS

View all profiles